share_log

JP Morgan Maintains Neutral on Alkermes, Lowers Price Target to $31

Benzinga ·  Jul 15 09:58

JP Morgan analyst Jessica Fye maintains Alkermes (NASDAQ:ALKS) with a Neutral and lowers the price target from $32 to $31.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment